Latest Trigeminal nerve Stories
LOS ANGELES, Nov. 3, 2014 /PRNewswire/ -- NeuroSigma(®), Inc.
Subcutaneous Trigeminal Nerve Stimulation (sTNS) for the Treatment of Neuropsychiatric Disorders LOS ANGELES, Oct. 21, 2014 /PRNewswire/ - NeuroSigma(®), Inc.
Phase 1 Clinical Trial - External Trigeminal Nerve Stimulation for Traumatic Brain Injury LOS ANGELES, Oct. 15, 2014 /PRNewswire/ -- NeuroSigma(®), Inc.
CyberKnife center offers nonsurgical option for lesser-known nerve disorder known as "suicide disease" LOUISVILLE, Ky., Oct.
Company to exhibit nerve repair technologies at Booth 644 Alachua, FL (PRWEB) September 09, 2014 A
European Clinical Data and Mechanism of Action Results Presented LOS ANGELES, July 8, 2014 /PRNewswire/ -- NeuroSigma, Inc.
Carl Adams Promoted to Chief Financial Officer and Craig Rostamian Joins as Vice President of Finance LOS ANGELES, March 28, 2014 /PRNewswire/ -- NeuroSigma, Inc.
Research by Beaumont Health System radiation oncologists and neurosurgeons found that symptoms of trigeminal neuralgia, or TN, a nerve disorder causing severe facial pain, were reduced in those treated with Gamma Knife stereotactic radiosurgery.
Using ultrasound guidance for facial injection is highly effective in treating trigeminal neuralgia CHICAGO, Feb.
LOS ANGELES, Feb. 25, 2014 /PRNewswire/ -- NeuroSigma, Inc.
- To swell, as grain or wood with water.